They do raise capital in the sense that the Chairman subscribes to the DRP. It's an interesting company because whereas traditionally the CEO is in charge of capital allocation, the wisdom of paying a dividend depends largely on whether the Chairman reinvests his dividend.
I've speculated about whether the company will pay a dividend... they could, and that would get the franking credits out, which is nice. Also, reinvestment probably makes a lot of sense at the current market price.
If they maintain the dividend they'll be using some of their cash reserves, but as you say, the seem to run a tight ship. Personally, I think cutting the dividend would make sense too, although the market might react negatively to that. As long as some of their current initiatives pay off, we should be sitting pretty in the long term.
- Forums
- ASX - By Stock
- MVP
- some research
MVP
medical developments international limited
Add to My Watchlist
4.74%
!
60.8¢

some research, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.8¢ |
Change
0.028(4.74%) |
Mkt cap ! $68.43M |
Open | High | Low | Value | Volume |
58.0¢ | 63.0¢ | 58.0¢ | $15.35K | 25.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25900 | 59.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
63.0¢ | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25900 | 0.590 |
1 | 1571 | 0.585 |
1 | 8973 | 0.555 |
2 | 23925 | 0.550 |
1 | 931 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.630 | 3000 | 1 |
0.635 | 4580 | 1 |
0.640 | 6264 | 1 |
0.650 | 2090 | 2 |
0.670 | 77 | 1 |
Last trade - 15.53pm 04/07/2025 (20 minute delay) ? |
Featured News
MVP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online